HOME >> MEDICINE >> NEWS
Federal policy has failed to prepare nation for possibility of bioterrorism

CHAMPAIGN, Ill. -- The U.S. Centers for Disease Control and Prevention confirms a case of smallpox in a Midwest city. Minutes later, officials declare that the country is under a terrorist smallpox attack. Panicked families swamp hospital emergency rooms nationwide.

The federal government makes immediate plans to inoculate 3.5 million people, but most of the emergency-response teams, including most emergency-room doctors, have not been vaccinated for the virus. Many do not show up for work, stymieing attempts to isolate the outbreak and adding to the growing death toll.

This scenario of unpreparedness is not fanciful, according to Michael H. LeRoy, a professor of industrial relations and of law at the University of Illinois at Urbana-Champaign. It reflects "a disturbing consensus among medical and national security experts" that, three years after the 9-11 attacks, federal policy has failed to prepare the nation for the possibility of bioterrorism through the deliberate spread of the variola (smallpox) virus.

Smallpox is highly contagious and kills about 30 percent of those infected. A scourge throughout most of human history, the virus in its natural state was eradicated in the United States by 1950. Smallpox vaccinations for the general public were ended in 1972.

"Why then so much alarm among experts?" LeRoy asked in a forthcoming article in the Emory Law Journal. One reason is that the virus, known to be stored in both a U.S. and former Soviet Union lab, could be weaponized in an aerosol form and released into a city block or large crowd.

"It spreads easily by normal human interaction," LeRoy said. Although the federal government does have large quantities of smallpox vaccine to inoculate the public, the virus could spread widely and rapidly among an unprotected population before those infected are diagnosed and put in isolation wards.

"After incubating for seven to 17 days, the first symptoms of smallp
'"/>

Contact: Mark Reutter, Business & Law Editor
mreutter@uiuc.edu
217-333-0568
University of Illinois at Urbana-Champaign
9-Sep-2004


Page: 1 2 3 4

Related medicine news :

1. Federal funds given for regenerative medicine center
2. Federal forum reports Americans aging well, but gaps remain
3. Federal institutes and the Robert Wood Johnson Foundation create Tobacco Use Research Centers
4. Federal, private funding to establish inflammatory disease center at UNC
5. Federal agencies report on nations children
6. Emory Receives $14 Million Federal Grant To Coordinate 50-Site Brain Attack Prevention Trial
7. Public policy should address the social factors behind ill health
8. End AIDS drug waiting lists, HIV care providers tell policymakers
9. Disease testing for immigrants: Discrimination disguised as public health policy
10. Public interest advocates question NIH Enhanced Access policy
11. Post election 2004: Whats in store for health policy

Post Your Comments:
(Date:8/3/2015)... ... August 03, 2015 , ... A July 13 article from The Daily ... to Release Natural Painkiller That Can Last 'For Five Weeks'" discusses the use ... the new study showed that harvesting stem cell-rich bone marrow from the hip, known ...
(Date:8/3/2015)... ... ... Illinois Health & Science (IHS) has completed the purchase of IBA Molecular North ... NA’s cyclotron sites and research and development facilities. , “We are excited ... a large manufacturing hub in Noblesville, Indiana,” said Ken Smithmier, President and CEO of ...
(Date:8/3/2015)... ... August 03, 2015 , ... Hub International Insurance ... Williams has joined its growing California employee benefits division. Mr. Williams will ... his clients. Mr. Williams will be joining the newly integrated Northern California employee ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... ... Government Programs, with accountability for overall performance of the company’s Medicare and Federal ... focus of Cambia’s strategy to deliver better health for members. In this role, ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... provider of medical information, risk management and investigative services, has introduced a ... toward focused, expert information solutions that improve business outcomes for its customers. ...
Breaking Medicine News(10 mins):Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 2Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 3Health News:Illinois Health & Science Expands Nuclear Medicine Footprint With Purchase of IBA Molecular North America, Inc. 2Health News:HUB International Insurance Services Announces Joe Williams Has Joined its Northern California Employee Benefits Division 2Health News:Cambia Health Solutions Names Scott Powers President of Government Programs 2Health News:EMSI Announces New Branding: Powerful Information. Improved Outcomes. 2
(Date:8/3/2015)... -- Encision Inc. (PK:ECIA), a medical device company owning patented ... minimally invasive surgery, today announced financial results for its ... The Company posted quarterly net revenue of ... thousand, or $(0.02) per share. These results compare to ... of $202 thousand, or $(0.02) per share, in the ...
(Date:8/2/2015)... , Aug. 3, 2015  Isis Pharmaceuticals, Inc. ... a strategic collaboration to discover and develop antisense ... new collaboration builds on a broad existing relationship ... approach in these therapeutic areas using novel RNA-targeted ... use of its antisense technology to diseases of ...
(Date:7/31/2015)... N.C. , July 31, 2015  In today,s ... customers who are increasingly mobile, increasingly connected, and increasingly ... growing variety of customer interaction channels and tools is ... including social media. According to research ... over the counter (OTC) segment in a call center ...
Breaking Medicine Technology:Encision Reports First Quarter Fiscal Year 2016 Results 2Encision Reports First Quarter Fiscal Year 2016 Results 3Encision Reports First Quarter Fiscal Year 2016 Results 4Encision Reports First Quarter Fiscal Year 2016 Results 5AstraZeneca and Isis Pharmaceuticals to Discover and Develop Antisense Drugs for Cardiovascular, Metabolic and Renal Diseases 2AstraZeneca and Isis Pharmaceuticals to Discover and Develop Antisense Drugs for Cardiovascular, Metabolic and Renal Diseases 3AstraZeneca and Isis Pharmaceuticals to Discover and Develop Antisense Drugs for Cardiovascular, Metabolic and Renal Diseases 4Best Practices in Building World-Class Consumer & Over-the-Counter Call Centers 2
Cached News: